Article (Scientific journals)
Quality of antimalarials in Kinshasa peri-urban areas with regard to local pharmaceutical legislation and regulation
Mavungu Landu, Don Jethro; Frederich, Michel; Manzambi Kuwekita, Joseph et al.
2020In International Health, 12 (4), p. 253–263
Peer Reviewed verified by ORBi
 

Files


Full Text
Manuscript_RSTMH_revised_AK.pdf
Author postprint (390.8 kB)
Download
Full Text Parts
Mavungu et al_Int Health_2019.pdf
Publisher postprint (1.73 MB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Characteristics of pharmacies; Democratic Republic of the Congo; Kinshasa; Peri-urban areas; Testing and Treatment Algorithm; Pharmaceutical legislation and regulation; Quality of antimalarials
Abstract :
[en] Background: In the context of old pharmaceutical legislation and regulations not adapted to current realities, the aim of the present studywas to evaluate the existing pharmaceutical system in peri-urban areas of Kinshasa. Methods: A prospective study was carried out during the period 2016–2018. The most used antimalarial medicines were identified through household and pharmaceutical establishment surveys. The samples of the obtained medicines were assayed with generic separation methods using the high-performance liquid chromatography technique coupled to a diode array detector. The registration status was checked for 126 antimalarial brand names. A characterization was carried out in 196 pharmaceutical establishments on the basis of standards set out by the Ministry of Health. Results: Of the 75 samples assayed, 19% (14/75)were non-compliant. Of the 124 brand names, 46.0% (57/124) were unlicensed and 14.5% (18/124) had an expired licence. Of the 196 pharmaceutical establishments, only 2 (1.0%) had an authorization to practice, none met all the Ministry of Health minimum standards and 24.5% (48/196) met the World Health Organization Guidelines for the Storage of Essential Medicines and Other Health Commodities. Conclusions: More resources should be mobilized to apply regulator sanctions.
Research Center/Unit :
CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Mavungu Landu, Don Jethro ;  Université de Liège - ULiège > Doct. sc. bioméd. & pharma. (paysage)
Frederich, Michel  ;  Université de Liège - ULiège > Département de pharmacie > Pharmacognosie
Manzambi Kuwekita, Joseph;  Liège University > Department of Public Health Sciences
Bongo-Pasi Nswe, Christian
Mbinze Kindenge, Jérémie;  Université de Kinshasa > Department of Galenic Pharmacy and Drug Analysis,
Liégeois, Sophie
Kalenda Tshilombo, Nicodème ;  Université de Liège - ULiège > Doct. sc. bioméd. & pharma. (paysage)
Mineze Kwete Minga
Ciza Hamuli, Patient  ;  Université de Liège - ULiège > Doct. sc. bioméd. & pharma. (paysage)
Hubert, Philippe  ;  Université de Liège - ULiège > Département de pharmacie > Chimie analytique
Marini Djang'Eing'A, Roland ;  Université de Liège - ULiège > Département de pharmacie > Chimie analytique
Language :
English
Title :
Quality of antimalarials in Kinshasa peri-urban areas with regard to local pharmaceutical legislation and regulation
Publication date :
2020
Journal title :
International Health
ISSN :
1876-3413
eISSN :
1876-3405
Publisher :
Elsevier, Netherlands
Volume :
12
Issue :
4
Pages :
253–263
Peer reviewed :
Peer Reviewed verified by ORBi
Name of the research project :
BioFakeF – (Bio)Medicines Fake to be Fight
Available on ORBi :
since 22 October 2019

Statistics


Number of views
169 (42 by ULiège)
Number of downloads
71 (21 by ULiège)

Scopus citations®
 
0
Scopus citations®
without self-citations
0
OpenCitations
 
1
OpenAlex citations
 
3

Bibliography


Similar publications



Contact ORBi